Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 28, 2020 at 05:28 am EDT
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,206.861 million compared to CNY 1,428.817 million a year ago. Operating income was CNY 54.308 million compared to operating loss of CNY 1,664.936 million a year ago. Net income was CNY 41.753 million compared to net loss of CNY 1,673.625 million a year ago. Basic earnings per share from continuing operations was CNY 0.0247 compared to basic loss per share from continuing operations of CNY 0.9885 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.